SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-002609
Filing Date
2024-03-06
Accepted
2024-03-06 16:16:21
Documents
118
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cara-20231231x10k.htm   iXBRL 10-K 3612380
2 EX-10.25 cara-20231231xex10d25.htm EX-10.25 551184
3 EX-21.1 cara-20231231xex21d1.htm EX-21.1 3516
4 EX-23.1 cara-20231231xex23d1.htm EX-23.1 14169
5 EX-31.1 cara-20231231xex31d1.htm EX-31.1 11698
6 EX-31.2 cara-20231231xex31d2.htm EX-31.2 11861
7 EX-32.1 cara-20231231xex32d1.htm EX-32.1 11194
8 EX-97 cara-20231231xex97.htm EX-97 41839
9 GRAPHIC cara-20231231x10k004.jpg GRAPHIC 45050
  Complete submission text file 0001558370-24-002609.txt   16057432

Data Files

Seq Description Document Type Size
10 EX-101.SCH cara-20231231.xsd EX-101.SCH 100886
11 EX-101.CAL cara-20231231_cal.xml EX-101.CAL 77450
12 EX-101.DEF cara-20231231_def.xml EX-101.DEF 514151
13 EX-101.LAB cara-20231231_lab.xml EX-101.LAB 787757
14 EX-101.PRE cara-20231231_pre.xml EX-101.PRE 723072
120 EXTRACTED XBRL INSTANCE DOCUMENT cara-20231231x10k_htm.xml XML 2707297
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36279 | Film No.: 24726084
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)